Nationwide extrapolation of economic benefit of therapeutic innovation: a 10-year retrospective budget impact of direct oral anticoagulants introduction in France.

Objectives: Patients with atrial fibrillation (AF) face increased risks of strokes and systemic thromboembolism (SE), traditionally managed with vitamin K antagonists (VKAs), which are associated with major bleeding (MB) risks. The nationwide real-life data-based NAXOS study, comparing Direct Oral A...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Medical Economics Vol. 28; no. 1; pp. 859 - 871
Autores principales:	Guilmet, C., Lesage, H., Cotté, F. E., Moreau, R., Marant Micallef, C., Née, M., Guitard-Dehoux, D., Belhassen, M., Danchin, N.
Formato:	Journal Article
Publicado:	Taylor & Francis Ltd Dec2025
Acceso en línea:	Ver este registro en EBSCOhost